1
|
Ali R, Hussain J, Lee SW. Multilayer perceptron-based self-care early prediction of children with disabilities. Digit Health 2023; 9:20552076231184054. [PMID: 37426585 PMCID: PMC10328031 DOI: 10.1177/20552076231184054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2022] [Accepted: 06/07/2023] [Indexed: 07/11/2023] Open
Abstract
Early identification of children with self-care impairments is one of the key challenges professional therapists face due to the complex and time-consuming detection process using relevant self-care activities. Due to the complex nature of the problem, machine-learning methods have been widely applied in this area. In this study, a feed-forward artificial neural network (ANN)-based self-care prediction methodology, called multilayer perceptron (MLP)-progressive, has been proposed. The proposed methodology integrates unsupervised instance-based resampling and randomizing preprocessing techniques to MLP for improved early detection of self-care disabilities in children. Preprocessing of the dataset affects the MLP performance; hence, randomization and resampling of the dataset improves the performance of the MLP model. To confirm the usefulness of MLP-progressive, three experiments were conducted, including validating MLP-progressive methodology over multi-class and binary-class datasets, impact analysis of the proposed preprocessing filters on the model performance, and comparing the MLP-progressive results with state-of-the-art studies. The evaluation metrics accuracy, precision, recall, F-measure, TP rate, FP rate, and ROC were used to measure performance of the proposed disability detection model. The proposed MLP-progressive model outperforms existing methods and attains a classification accuracy of 97.14% and 98.57% on multi-class and binary-class datasets, respectively. Additionally, when evaluated on the multi-class dataset, significant improvements in accuracies ranging from 90.00% to 97.14% were observed when compared to state-of-the-art methods.
Collapse
Affiliation(s)
- Rahman Ali
- Quaid-e-Azam College of Commerce, University of Peshawar, Khyber Pakhtunkhwa, Pakistan
| | - Jamil Hussain
- Department of Data Science, Sejong University, Seoul, Korea
| | - Seung Won Lee
- Sungkyunkwan University School of Medicine, Suwon, Korea
| |
Collapse
|
2
|
Mortazavi SAR, Tahmasebi S, Parsaei H, Taleie A, Faraz M, Rezaianzadeh A, Zamani A, Zamani A, Mortazavi SMJ. Machine Learning Models for Predicting Breast Cancer Risk in Women Exposed to Blue Light from Digital Screens. J Biomed Phys Eng 2022; 12:637-644. [PMID: 36569561 PMCID: PMC9759638 DOI: 10.31661/jbpe.v0i0.2105-1341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Accepted: 08/02/2021] [Indexed: 06/17/2023]
Abstract
BACKGROUND Nowadays, there is a growing global concern over rapidly increasing screen time (smartphones, tablets, and computers). An accumulating body of evidence indicates that prolonged exposure to short-wavelength visible light (blue component) emitted from digital screens may cause cancer. The application of machine learning (ML) methods has significantly improved the accuracy of predictions in fields such as cancer susceptibility, recurrence, and survival. OBJECTIVE To develop an ML model for predicting the risk of breast cancer in women via several parameters related to exposure to ionizing and non-ionizing radiation. MATERIAL AND METHODS In this analytical study, three ML models Random Forest (RF), Support Vector Machine (SVM), and Multi-Layer Perceptron Neural Network (MLPNN) were used to analyze data collected from 603 cases, including 309 breast cancer cases and 294 gender and age-matched controls. Standard face-to-face interviews were performed using a standard questionnaire for data collection. RESULTS The examined models RF, SVM, and MLPNN performed well for correctly classifying cases with breast cancer and the healthy ones (mean sensitivity> 97.2%, mean specificity >96.4%, and average accuracy >97.1%). CONCLUSION Machine learning models can be used to effectively predict the risk of breast cancer via the history of exposure to ionizing and non-ionizing radiation (including blue light and screen time issues) parameters. The performance of the developed methods is encouraging; nevertheless, further investigation is required to confirm that machine learning techniques can diagnose breast cancer with relatively high accuracies automatically.
Collapse
Affiliation(s)
| | - Sedigheh Tahmasebi
- MD, Breast Cancer Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hossein Parsaei
- PhD, Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
- PhD, Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Abdorasoul Taleie
- MD, Breast Cancer Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mehdi Faraz
- MSc, Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Abbas Rezaianzadeh
- PhD, Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Atefeh Zamani
- PhD, Department of Statistics, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Ali Zamani
- PhD, Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyed Mohammad Javad Mortazavi
- PhD, Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
3
|
Belpomme D, Carlo GL, Irigaray P, Carpenter DO, Hardell L, Kundi M, Belyaev I, Havas M, Adlkofer F, Heuser G, Miller AB, Caccamo D, De Luca C, von Klitzing L, Pall ML, Bandara P, Stein Y, Sage C, Soffritti M, Davis D, Moskowitz JM, Mortazavi SMJ, Herbert MR, Moshammer H, Ledoigt G, Turner R, Tweedale A, Muñoz-Calero P, Udasin I, Koppel T, Burgio E, Vorst AV. The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report. Int J Mol Sci 2021; 22:7321. [PMID: 34298941 PMCID: PMC8304862 DOI: 10.3390/ijms22147321] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 06/23/2021] [Accepted: 06/26/2021] [Indexed: 02/07/2023] Open
Abstract
Clinical research aiming at objectively identifying and characterizing diseases via clinical observations and biological and radiological findings is a critical initial research step when establishing objective diagnostic criteria and treatments. Failure to first define such diagnostic criteria may lead research on pathogenesis and etiology to serious confounding biases and erroneous medical interpretations. This is particularly the case for electrohypersensitivity (EHS) and more particularly for the so-called "provocation tests", which do not investigate the causal origin of EHS but rather the EHS-associated particular environmental intolerance state with hypersensitivity to man-made electromagnetic fields (EMF). However, because those tests depend on multiple EMF-associated physical and biological parameters and have been conducted in patients without having first defined EHS objectively and/or endpoints adequately, they cannot presently be considered to be valid pathogenesis research methodologies. Consequently, the negative results obtained by these tests do not preclude a role of EMF exposure as a symptomatic trigger in EHS patients. Moreover, there is no proof that EHS symptoms or EHS itself are caused by psychosomatic or nocebo effects. This international consensus report pleads for the acknowledgement of EHS as a distinct neuropathological disorder and for its inclusion in the WHO International Classification of Diseases.
Collapse
Affiliation(s)
- Dominique Belpomme
- Association for Research Against Cancer (ARTAC), 57/59 rue de la Convention, 75015 Paris, France;
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
| | - George L. Carlo
- The Science and Public Policy Institute, Washington, DC 20006, USA;
| | - Philippe Irigaray
- Association for Research Against Cancer (ARTAC), 57/59 rue de la Convention, 75015 Paris, France;
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
| | - David O. Carpenter
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
- Institute for Health and the Environment, University at Albany, Albany, NY 12222, USA
- Child Health Research Centre, Faculty of Medicine, The University of Queensland, South Brisbane, QLD 4101, Australia
| | - Lennart Hardell
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
- The Environment and Cancer Research Foundation, SE-702 17 Örebro, Sweden
| | - Michael Kundi
- Center for Public Health, Department of Environmental Health, Medical University of Vienna, 1090 Vienna, Austria; (M.K.); (H.M.)
| | - Igor Belyaev
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
- Biomedical Research Center, Slovak Academy of Science, 845 05 Bratislava, Slovakia
| | - Magda Havas
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
- Trent School of the Environment, Trent University, 1600 West Bank Drive, Peterborough, ON K9J 0G2, Canada
| | - Franz Adlkofer
- Verum-Foundation for Behaviour and Environment c/o Regus Center Josephspitalstrasse 15/IV, 80331 München, Germany;
| | - Gunnar Heuser
- Formerly UCLA Medical Center, Department of Medicine, P.O. Box 5066, El Dorado Hills, Los Angeles, CA 95762, USA;
| | - Anthony B. Miller
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S, Canada;
| | - Daniela Caccamo
- Department of Biomedical Sciences, Dental Sciences and Morpho Functional Imaging, Polyclinic Hospital University, 98122 Messina, Italy;
| | - Chiara De Luca
- Department of Registration & Quality Management, Medical & Regulatory Affairs Manager, MEDENA AG, 8910 Affoltern am Albis, Switzerland;
| | - Lebrecht von Klitzing
- Medical Physicist, Institute of Environmental and Medical Physic, D-36466 Wiesenthal, Germany;
| | - Martin L. Pall
- School of Molecular Biosciences, Washington State University, Pullman, WA 99164, USA;
| | - Priyanka Bandara
- Oceania Radiofrequency Scientific Advisory Association (ORSAA), P.O. Box 152, Scarborough, QLD 4020, Australia;
| | - Yael Stein
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91905, Israel;
- Hadassah Medical Center, Department of Anesthesiology, Critical Care and Pain Medicine, Jerusalem 91905, Israel
| | - Cindy Sage
- Sage Associates, Montecito, Santa Barbara, CA 93108, USA;
| | - Morando Soffritti
- Istituto Ramazzini, via Libia 13/A, 40138 Bologna, Italy;
- Collegium Ramazzini, Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio, Italy
| | - Devra Davis
- Environmental Health Trust, P.O. Box 58, Teton Village, WY 83025, USA;
| | - Joel M. Moskowitz
- School of Public Health, University of California, Berkeley, CA 94720, USA;
| | - S. M. J. Mortazavi
- Medical Physics and Medical Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz P.O. Box 71348-14336, Iran;
- Ionizing and Non-ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz P.O. Box 71348-14336, Iran
| | - Martha R. Herbert
- A.A. Martinos Centre for Biomedical Imaging, Department of Neurology, MGH, Harvard Medical School, MGH/MIT/Harvard 149 Thirteenth Street, Charlestown, MA 02129, USA;
| | - Hanns Moshammer
- Center for Public Health, Department of Environmental Health, Medical University of Vienna, 1090 Vienna, Austria; (M.K.); (H.M.)
- Department of Hygiene, Karakalpak Medical University, Nukus 230100, Uzbekistan
| | - Gerard Ledoigt
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
| | - Robert Turner
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA;
- Clinical Pediatrics and Neurology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA
| | - Anthony Tweedale
- Rebutting Industry Science with Knowledge (R.I.S.K.) Consultancy, Blv. Edmond Machtens 101/34, B-1080 Brussels, Belgium;
| | - Pilar Muñoz-Calero
- Foundation Alborada, Finca el Olivar, Carretera M-600, Km. 32,400, 28690 Brunete, Spain;
| | - Iris Udasin
- EOHSI Clinical Center, School of Public Health, Rutgers University, Piscataway, NJ 08854, USA;
| | - Tarmo Koppel
- AI Institute, University of South Carolina, Columbia, SC 29208, USA;
| | - Ernesto Burgio
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
| | - André Vander Vorst
- European Cancer and Environment Research Institute (ECERI), 1000 Brussels, Belgium; (D.O.C.); (L.H.); (I.B.); (M.H.); (G.L.); (E.B.); (A.V.V.)
- European Microwave Association, Rue Louis de Geer 6, B-1348 Louvain-la-Neuve, Belgium
| |
Collapse
|
4
|
Mortazavi SMJ, Aminiazad F, Parsaei H, Mosleh-Shirazi MA. AN ARTIFICIAL NEURAL NETWORK-BASED MODEL FOR PREDICTING ANNUAL DOSE IN HEALTHCARE WORKERS OCCUPATIONALLY EXPOSED TO DIFFERENT LEVELS OF IONIZING RADIATION. RADIATION PROTECTION DOSIMETRY 2020; 189:98-105. [PMID: 32103272 DOI: 10.1093/rpd/ncaa018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2019] [Revised: 12/26/2019] [Accepted: 02/10/2020] [Indexed: 06/10/2023]
Abstract
We presented an artificial intelligence-based model to predict annual effective dose (AED) value of health workers. Potential factors affecting AED and the results of annual blood tests were collected from 91 radiation workers. Filter-based feature selection strategy revealed that the eight factors plate, red cell distribution width (RDW), educational degree, nonacademic course in radiation protection (hour), working hours per month, department and the number of procedures done per year and work in radiology department or not (0,1) were the most important predictors for AED. The prediction model was developed using a multilayer perceptron neural network and these prediction parameters as inputs. The model provided favorable accuracy in predicting AED value while a regression model did not. There was a strong linear relationship between the predicted AED values and the measured doses (R-value =0.89 for training samples and 0.86 for testing samples). These results are promising and show that artificial neural networks can be used to improve/facilitate dose estimation process.
Collapse
Affiliation(s)
- S M J Mortazavi
- Department of Medical Physics and Engineering, School of Medicine, Zand Blvd., Shiraz, Fars, 7134845794, Iran
- Ionizing and Non-ionizing Radiation Protection Research Center, School of Paramedical Sciences, Opposite Homa Hotel, Meshkinfam St., Shiraz 71439-14693, Iran
| | - Fatemeh Aminiazad
- Department of Medical Physics and Engineering, School of Medicine, Zand Blvd., Shiraz, Fars, 7134845794, Iran
| | - Hossein Parsaei
- Department of Medical Physics and Engineering, School of Medicine, Zand Blvd., Shiraz, Fars, 7134845794, Iran
- Shiraz Neuroscience Research Center, Chamran Hospital, Chamran Boulevard, Shiraz 7194815644, Iran
| | - Mohammad Amin Mosleh-Shirazi
- Ionizing and Non-ionizing Radiation Protection Research Center, School of Paramedical Sciences, Opposite Homa Hotel, Meshkinfam St., Shiraz 71439-14693, Iran
- Physics Unit, Department of Radiotherapy and Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz 71936-13311, Iran
| |
Collapse
|